Cargando…
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) treated with immune checkpoint inhibitors (ICIs) are at risk of pneumonitis as well as pneumonia (combined henceforth as ICI-related pulmonary complications). Little is known about the cellular and molecular mechanisms und...
Autores principales: | Kim, Sang T., Sheshadri, Ajay, Shannon, Vickie, Kontoyiannis, Dimitrios P., Kantarjian, Hagop, Garcia-Manero, Guillermo, Ravandi, Farhad, Im, Jin S., Boddu, Prajwal, Bashoura, Lara, Balachandran, Diwakar D., Evans, Scott E., Faiz, Saadia, Ruiz Vazquez, Wilfredo, Divenko, Margarita, Mathur, Rohit, Tippen, Samantha P., Gumbs, Curtis, Neelapu, Sattva S., Naing, Aung, Wang, Linghua, Diab, Adi, Futreal, Andrew, Nurieva, Roza, Daver, Naval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859512/ https://www.ncbi.nlm.nih.gov/pubmed/33552049 http://dx.doi.org/10.3389/fimmu.2020.590494 |
Ejemplares similares
-
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
por: Short, Nicholas J., et al.
Publicado: (2019) -
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept
por: Aminu, Muhammad, et al.
Publicado: (2023) -
Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021) -
Pre-leukemic clonal hematopoiesis and the risk of therapy-related
myeloid neoplasms: a case-control study
por: Takahashi, Koichi, et al.
Publicado: (2016) -
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
por: Takahashi, Koichi, et al.
Publicado: (2016)